Adverse event reports, internal safety communications, labeling records, regulatory correspondence- these documents require reviewers who can distinguish what is legally significant from what is scientifically routine.
We deploy TAR 2.0 with Continuous Active Learning alongside attorney-supervised review teams, building protocols around the specific litigation type rather than a generic responsiveness framework. Every production is defensible. Every privilege log is built to hold up.
A pharmaceutical company's contract portfolio doesn't just carry commercial risk, it carries regulatory accountability. Agreements with research partners (CROs), manufacturers (CMOs), and quality teams all come with rules set by regulators like the FDA, GMP, GCP, and HIPAA. If those rules aren’t tracked properly, the fallout isn’t only legal — it can disrupt day-to-day operations too.
We take care of the entire contract process: keeping track of obligations, sending renewal reminders, managing versions, and monitoring compliance — all aligned with the regulations pharma companies actually work under.
Stay updated with the latest legal insights, industry news, and company updates.
We use cookies and similar technologies for analytics and personalization. You can accept, reject, or customize your cookie settings at any time.